CCP
WST icon

Carmel Capital Partners’s West Pharmaceutical WST Stock Holding History

Carmel Capital Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-40
Closed -$15K – 715
2023
Q3 		$15K Buy
+40
New +$15.5K 0.01% 391

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Carmel Capital Partners's WST Position: Q4 2023 in Review

Carmel Capital Partners sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 40 shares — an estimated $15K sold.

Carmel Capital Partners first reported a position in WST in Q3 2023 and held it in 1 quarter. The position peaked at $15K in Q3 2023. 782 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Carmel Capital Partners reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Carmel Capital Partners sold 40 West Pharmaceutical shares in Q4 2023, an estimated $15K.
  • Carmel Capital Partners first reported a position in West Pharmaceutical in Q3 2023 and held it in 1 quarter.
  • Carmel Capital Partners's West Pharmaceutical position peaked at $15K in Q3 2023.
  • 782 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.